Aquaporin lowers revenue guidance for 2025, but maintains EBITDA guidance, and initiates strategic review

Company announcementNo. 15/2025Inside information

Aquaporin A/SNymøllevej 78DK-2800 Kongens Lyngbyaquaporin.comCompany registration no.: DK28315694

KONGENS LYNGBY, Denmark, Aug. 11, 2025 /PRNewswire/ -- Aquaporin A/S (ticker: AQP) ("Aquaporin" or the "Company"), an innovative water technology company dedicated to rethinking water filtration with biotechnology, today announces, pursuant to the Market Abuse Regulation on publication of inside information, that the Company is lowering its revenue guidance for the financial year ending December 31, 2025, previously published on March 20, 2025, and initiates a strategic review to strengthen its capital structure.

The updated revenue guidance is adjusted to DKK 40-50 million (previously DKK 60-80 million). Aquaporin's three business areas, Residential Drinking Water, Industrial Water, and Forward Osmosis Market Development, are expected to contribute approximately equally to the consolidated revenue in 2025. The guidance for EBITDA (before special items) remains unchanged with an expected loss in the range of DKK (45)-(55) million.

The revised revenue guidance is the result of a lower inflow of orders in 2025 as well as a delay in certain orders. The updated range includes already-recognized revenue, firm commitments, and a larger soft commitment. In line with previous years, the Company expects the largest part of the revenue to materialize in the second half of 2025.

"Although the run-up to materialize orders in 2025 has been slower than expected, I believe Aquaporin has a strong foundation in terms of pipeline and potential to progress its commercial traction in the coming ...